Container
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of a container showing our new design;
FIG. 2 is a left side elevation view thereof, the right side elevation view being a mirror image;
FIG. 3 is a bottom plan view thereof;
FIG. 4 is a front elevation view thereof;
FIG. 5 is a top plan view thereof;
FIG. 6 is a rear elevation view thereof.
Referenced Cited
Patent History
Patent number: D307388
Type: Grant
Filed: Feb 19, 1987
Date of Patent: Apr 24, 1990
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Paul K. Rand (Hitchin)
Primary Examiner: Charles A. Rademaker
Assistant Examiner: Prabhakar Deshmukh
Law Firm: Darby & Darby
Application Number: 7/16,322
Type: Grant
Filed: Feb 19, 1987
Date of Patent: Apr 24, 1990
Assignee: Glaxo Group Limited (London)
Inventors: Robert E. Newell (Pinner), Paul K. Rand (Hitchin)
Primary Examiner: Charles A. Rademaker
Assistant Examiner: Prabhakar Deshmukh
Law Firm: Darby & Darby
Application Number: 7/16,322
Classifications
Current U.S. Class:
D/9345